Senior Director, Corporate Development

TerraPower•Everett, WA

19h

About The Position

The Senior Director of Corporate Development owns the long-horizon growth architecture of TerraPower Isotopes across mergers and acquisitions, partnerships, alternative revenue structures, and capital planning. Reporting to the Vice President of Commercial and Strategy, the role is distinct from day-to-day sales and account management and focuses on determining which organizations TPI should work with, on what terms, and how the business should be financed. The successful candidate will bring transaction experience in radiopharmaceuticals or nuclear medicine, financial expertise to independently value and structure deals, and the ability to operate as a senior individual contributor while the company scales through a capital-intensive build. The position also develops revenue and financing approaches, tracks market and pipeline developments, and ensures corporate development activity complies with applicable export control, antitrust, competition, and confidentiality requirements. Regular travel to TerraPower Isotopes facilities, counterparty sites, and international partner locations is required; the stated travel range is 0–10%. TerraPower Isotopes is part of TerraPower, a Washington State-based company focused on new nuclear technologies and advancing medical isotope development for radiotherapies and other nuclear-related medical treatments. TerraPower is an Equal Opportunity Employer. The work involves extended sitting, bending or stooping, grasping or gripping, fine motor control, prolonged repetitive work, visually and aurally focused tasks, stairs, and typing or keyboard use. The standard working environment may involve more than eight hours per day. Physical exertion is minimal, with the ability to safely lift up to 25 pounds. Workplace accommodations may be considered on a case-by-case basis following an individualized assessment.

Requirements

Bachelor’s degree in finance, business, engineering, life sciences, or a related field.
At least 15 years of progressive experience in corporate development, investment banking, private equity, or strategic finance, including substantial experience in radiopharmaceuticals, nuclear medicine, pharmaceuticals, or medical devices.
Demonstrated ownership of completed transactions from origination through close, including valuation, diligence, structuring, and negotiation.
Deep working knowledge of the radiopharmaceutical value chain, including isotope production economics, clinical development timelines, and the reimbursement environment for radiotherapeutics.
Advanced financial modeling capability, including the ability to build, audit, and defend valuation and long-range planning models without analytical support.
Experience evaluating and structuring non-cash consideration, such as equity or royalty interests.
Experience presenting recommendations to and defending them before boards of directors, investment committees, or comparable governing bodies.
Ability to operate as a senior individual contributor and build and lead a team as the business scales.
Excellent written communication and ability to turn complex financial and strategic analysis into concise, decision-ready materials.
Passion for mission-driven innovation in nuclear medicine and radiopharmaceuticals.
High degree of trust and integrity, open communication, respect, and a desire to foster teamwork.
Ability to travel regularly to facilities, counterparty sites, and international partner locations.
Ability to safely lift up to 25 pounds and perform the described physical functions, with or without accommodation.
Applicants who are foreign nationals may be subject to U.S. Government export control evaluation and authorization requirements; applicants will be asked to identify applicable U.S. citizenship or immigration status.

Nice To Haves

MBA, CFA, or advanced degree.

Responsibilities

Originate, screen, and prioritize acquisition, merger, joint venture, and partnership opportunities against TPI’s strategic position and capital constraints.
Build and defend discounted cash flow, comparable company, transaction, and scenario-based valuation models to withstand external advisor and Board scrutiny.
Lead financial and commercial diligence, integrating technical, legal, quality, and regulatory workstreams into a unified view of value and risk.
Structure transaction terms and governance, support negotiations through signing, and prepare Board-level materials that present risks, rewards, and alternatives objectively.
Develop post-close integration plans, including synergy definition, sequencing, and tracking against the deal case.
Design and evaluate alternatives to unit-priced supply, modeling the trade-off between near-term realized price and long-term participation in customer product value.
Assess counterparty creditworthiness, clinical probability of success, and dilution exposure when non-cash consideration is contemplated.
Develop and maintain the long-range financial plan linking production capacity expansion, revenue ramp, and capital requirements.
Evaluate equity, debt, project finance, government, and strategic-partner funding alternatives based on cost of capital, dilution, covenants, and control.
Prepare fundraising materials, including financial models and data room content, respond to investor and lender diligence, support financing-term negotiations, and maintain relationships with banking, lending, and advisory counterparties.
Maintain current intelligence on the alpha therapy and broader radiopharmaceutical landscape, including clinical pipelines, isotope supply capacity, competitor economics, and transaction comparables.
Identify developers, contract manufacturers, and suppliers for potential relationships and articulate the strategic rationale for each.
Track public and private market valuations relevant to TPI and deliver concise analytical briefs to the Vice President of Commercial and Strategy and TPI Leadership Team.
Ensure corporate development activity complies with export control requirements, antitrust and competition law, and transaction confidentiality obligations.
Coordinate with legal counsel on transaction documentation, disclosure obligations, and regulatory approval pathways.
Travel to TerraPower Isotopes facilities, counterparty sites, and international partner locations as required.

Benefits

Competitive compensation and eligibility to participate in discretionary short-term incentive payments.
Comprehensive medical and wellness benefits.
Medical insurance.
Vision insurance.
Dental insurance.
Life and disability benefits.
Gender affirmation benefits.
Parental leave.
401(k) plan.
Generous paid time off: 21 days accrued annually.
10 paid holidays.
Relocation assistance.
Professional and educational support opportunities.